Drugs / autologous bone marrow stem cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01068561 | May 2009 → Jan 2010 | retinitis pigmentosa | University of Sao Paulo | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01560715 | Jun 2011 → Jan 2013 | retinitis pigmentosa | University of Sao Paulo | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous bone marrow stem cells | “autologous bone marrow stem cells” NCT01560715 ↗ |
| Modality | Cell therapy | “autologous bone marrow stem cells” NCT01068561 ↗ |
| Route | Intravitreal | “intravitreal injection” NCT01068561 ↗ |